Suzanne Bujara

Researchers found data that show adverse lifestyle factors increase the risk for depression.

Researcher data showed that the boundaries to successful treatment in depression in patients who are minorities are varied, but that there are certain predisposing factors such as adverse childhood events and genetics.

Researchers found data to support their hypothesis that developmental stress vulnerability is the link between a predisposition and environmental triggers in the pathophysiology of schizophrenia.

Researchers found a small number of clinical trials that indicated antidepressant effects of cytokine blockers.

Researchers found that the inclusion of significant others in cognitive behavioral therapy for victims of violent crimes is beneficial for the victim and indirect victim.

Researchers found no association between depression severity and brain-derived neurotrophic factor (BDNF) levels, and no correlation between BDNF levels and response to electroconvulsive therapy.

Clinicians should be discerning when evaluating meta-analyses of schizophrenia add-on therapies such as statins and antidepressants.

The European Medicine Agency has reported that there may be an association between long-term lithium use and reports of both renal tumors and thyroid cancer.

Given the substantial burden of nonadherence to therapy in patients with schizophrenia, new interventions for compliance are critical.

As depression is one of the most common psychiatric disorders following acute stroke and can be predictive of poor outcomes, identifying biomarkers to recognize the disorder are imperative for improving the clinical course.

When alcohol and opioid addiction occur together, managing them concomitantly becomes challenging. Whereas some patients may not need medication for alcohol addiction, opioid abuse does require pharmacotherapy.

The opioid system is responsible for social pain and reward in the brain; therefore, understanding its underpinnings may help clinicians manage patients with depression and suicidal ideation.

Screening for cardiovascular disease risk is recommended for clinicians who manage patients with bipolar disorder.

With better understanding of the underlying mechanisms of transcranial direct current stimulation, clinicians will be better equipped to identify the optimal management of their patients with major depressive disorder.

Bipolar disorder is often comorbid with substance use disorders, with alcohol being the top substance. Clinicians should take a thorough history to uncover substance use disorder because it will guide the management of both disorders.

Before the next set of guidelines are updated and harmonized, individual studies may provide direction for clinicians.

The erythematotelangiectatic, papulopustular, phymatous, and ocular forms of rosacea can lead to psychological distress.

Patients will still be at risk for schizophrenia or bipolar disorder even several years after an episode of substance-induced psychosis.

Mental health problems are 1 of the most important reasons for failing to engage in long-term control of HIV.

ADHD’s many deficits cannot be ameliorated by pharmacotherapy alone. Researchers and clinicians are investigating computer interventions and physical activity that get to the root of the ADHD domain, such as inattention, memory, or time management.

Raloxifene has demonstrated mostly positive results in meta-analyses of men and women with schizophrenia who received the selective estrogen receptor modulator as adjunctive therapy.

Although the theory of the gut-brain axis has existed for more than a century, recent studies are now examining how gut microbiota influence mood.

Dermatologic diseases such as acne, psoriasis and atopic dermatitis frequently have psychiatric comorbidities such as depression or suicidal ideation.